You are here: All Products  > NeuPharma Doses First Patient in Phase II Trial of Novel Inhibitor for Cancer

NeuPharma Doses First Patient in Phase II Trial of Novel Inhibitor for Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products